Elsevier

Drug and Alcohol Dependence

Volume 143, 1 October 2014, Pages 173-180
Drug and Alcohol Dependence

Correlates of polysomnographic sleep changes in cocaine dependence: Self-administration and clinical outcomes

https://doi.org/10.1016/j.drugalcdep.2014.07.025Get rights and content

Abstract

Background

Abstinence from chronic cocaine use is associated with abnormal sleep architecture. As sleep abnormalities are associated with clinical outcome in alcohol dependence, we hypothesized a similar relationship in cocaine dependence.

Methods

We report data from a cocaine self-administration study (N = 12) and the placebo arm of a randomized clinical trial (N = 20). Self-administration participants underwent three cocaine self-administration sessions during a three-week inpatient stay. Treatment participants underwent two weeks of inpatient followed by six weeks of outpatient treatment including once-weekly cognitive behavioral therapy. Measurements included polysomnography from early and late in abstinence during the inpatient stays. Clinical outcomes included amount of cocaine self-administered, urine tests, and self-reported use and withdrawal symptoms.

Results

Change in slow-wave sleep from early to late abstinence (ΔSWS; p = 0.05), late abstinence rapid eye movement sleep (REM; p = 0.002), and late abstinence total sleep time (p = 0.02) were negatively correlated with the amount of cocaine self-administered. Early abstinence REM was positively correlated with withdrawal symptoms (p = 0.02). Late abstinence REM was positively correlated with percent negative urines and maximum consecutive number of days abstinent (both p < 0.001). ΔSWS was positively correlated with percent negative urines (p = 0.03) and participants with increased SWS had greater percent negative urines (p = 0.008) and maximum consecutive number of days abstinent (p = 0.009).

Conclusions

Correlations between sleep deficits and amount of cocaine self-administered, clinical outcomes, and severity of withdrawal symptoms underscore the relevance of sleep in clinical outcomes in the treatment of cocaine dependence.

Introduction

Cocaine use disorders exert a global impact. Not only has cocaine use increased in Europe and in some West African countries within the past decade (Degenhardt et al., 2011), but evidence-based ranking of addictive substances, using categories such as physical harm, dependence, and social stigma, has also listed cocaine as the second most harmful drug, after heroin (Nutt et al., 2007). North America has the world's highest prevalence rates for cocaine dependence, estimated at 1.6 million cases (Degenhardt et al., 2013). Despite reductions from peak use in the 1980s and 1990s, cocaine use remains a significant problem in the United States. In 2012, there were more current and more new users of cocaine than of heroin and methamphetamine combined (National Survey on Drug Use and Health, 2013). Despite decades of research into potential pharmacological treatment of cocaine dependence, no medication has been approved by the FDA to treat this condition.

In order to identify an effective pharmacotherapy that could be added to current psychosocial interventions (Simpson et al., 1999), one of the targets considered has been the disruption in sleep associated with chronic use of cocaine and withdrawal there from. This interest stems both from previous findings in cocaine users by our group and others, and from multiple findings on alcohol use disorders dating back to the 1970s (Allen et al., 1971, Allen et al., 1977, Allen and Wagman, 1975). One of the earliest studies on sleep in alcoholics found that rapid eye movement sleep, measured as a percentage of total sleep (REM%) decreased after 2–3 days of withdrawal but rebounded after 5–6 days (Allen et al., 1971). Later, this group demonstrated the potential clinical value of objectively measured sleep abnormalities: low REM% was positively correlated with response rate in a button-press task to obtain an alcoholic drink faster (Allen and Wagman, 1975). While some of the above findings on REM have been difficult to replicate, new findings have emerged. For instance, one study showed that persons with alcohol dependence who relapsed within 3 months of an inpatient admission had increased REM%, rather than decreased, and had shorter REM latency upon admission and upon discharge, in comparison with persons who remained abstinent (Gillin et al., 1994).

Other work has examined changes in the slow wave sleep (SWS) of alcohol users. This work ranges from documenting the potential ability of acute alcohol use to increase SWS (Gross and Hastey, 1975) to several reports of abnormally low SWS among alcohol users, an effect that may remain for months (Brower, 2003). When it comes to the potential clinical relevance of SWS, Allen and colleagues examined SWS% in nine inpatients and found that subjects with poor outcomes had lower levels of SWS% at baseline, in comparison with the subjects who had good outcomes (Allen et al., 1977). Nevertheless, similar to the literature on REM, some findings on SWS have not been strongly replicated. For instance, study by Gillin et al. (1994) showed no differences in Stage 3 or Stage 4 NREM sleep between abstainers and relapsers. In another study, subjects who relapsed had lower percentages of Stage 4 NREM sleep, but not SWS overall (Brower et al., 1998).

Intriguingly, deficits in SWS have been observed in chronic users of other addictive substances including central nervous system depressants such as heroin (Schierenbeck et al., 2008), stimulants such as amphetamines and cocaine (Thompson et al., 1995), and cannabis (Barratt et al., 1974, Bolla et al., 2008). Decreased SWS has been found early in abstinence and during sub-acute withdrawal from cocaine use (Angarita et al., 2014, Morgan et al., 2010, Schierenbeck et al., 2008) in addition to other polysomnographic changes present during the first weeks of abstinence from cocaine (Matuskey et al., 2011, Morgan et al., 2006, Morgan et al., 2008, Morgan et al., 2010). These changes include early REM rebound (Pace-Schott et al., 2005), prolongation of REM latency (Angarita et al., 2014), and decreases in REM, SWS, and total sleep time (TST) during the first 3 weeks of abstinence (Angarita et al., 2014, Morgan et al., 2006, Morgan et al., 2008, Morgan et al., 2010, Pace-Schott et al., 2005, Thompson et al., 1995).

Lastly, subjective self-reports of sleep may impact clinical outcomes in chronic substance users. For example, answering yes to the statement, “it takes me a long time to fall asleep” on the Nottingham Health Profile (NHP) questionnaire differentiated those who relapsed from those who abstained from alcohol (Foster et al., 1998). Another study, also among alcohol dependent subjects, demonstrated that the presence of subjective sleep disruption increased the likelihood of relapse (Brower et al., 2001). However, cocaine users exhibit the opposite trend of alcoholics when it comes to the clinical utility of subjective sleep measurements. Early work on inpatient cocaine dependent subjects studied for 28 days found conflicting subjective reports such as improvement on several sleep measurements (e.g., sleep quality) on one hand, and difficulties falling asleep, on the other (Weddington et al., 1990). Our group has shown that cocaine users report experiencing better sleep as abstinence progresses, despite the objective deterioration of multiple sleep measures along with worsening sleep-related cognitive function (Morgan et al., 2006). This discrepancy between subjective self-report and objective polysomnographic measurements has been replicated (Angarita et al., 2014).

However; in spite of the prior research on subjective and objective sleep abnormalities in chronic cocaine users, no work to date has associated sleep parameters during the initial abstinence period with later cocaine use or relapse.

The purpose of this work was to test for such an association by measuring sleep during confirmed abstinence in an inpatient setting as a predictor of two clinical phenotypes: laboratory cocaine self-administration (number of doses delivered) and use-related clinical outcome during treatment (i.e., percentage of urine tests negative for cocaine and maximum consecutive number of days abstinent). To that end, we performed secondary analyses from two cohorts of participants: the first was a group of non-treatment seeking, cocaine dependent participants who self-administered cocaine during a period of inpatient abstinence; the second was a group participating in a combined inpatient-outpatient treatment protocol. Given that baseline sleep measures such as TST, SWS, and REM are perturbed in abstinent cocaine users relative to age matched controls, and considering that normalization of sleep measures have shown to be related to clinical outcomes in alcohol dependent patients, we hypothesized that decreased TST, SWS, and REM sleep measurements during abstinence, and the lack of normalization in those measurements in response to further abstinence, would positively correlate with worse clinical outcomes (e.g., more cocaine self-administration and lower percentage of negative urines/maximum number of consecutive days abstinent).

Section snippets

Participants

Data is presented from two groups: (1) a “self-administration group” consisting of non-treatment seeking cocaine dependent individuals (N = 12) who participated in a laboratory study of intravenous cocaine self-administration (Morgan et al., 2008) and (2) a “treatment group” consisting of treatment-seeking cocaine dependent individuals enrolled in an ongoing clinical trial on modafinil who were randomized to receive placebo (N = 20).

All participants met DSM-IV criteria for cocaine dependence, had

Demographics

Demographic and baseline information is provided in Table 1. Subjects in the treatment group were older (44.6 vs. 38.6 years old; t = 2.4; p = 0.02) and had been using cocaine for longer than subjects on the self-administration group (25.2 vs. 17.4 years; t = 2.8; p = 0.008). In the treatment group, 3 individuals out of the initial 20 did not begin the outpatient period and therefore provided no cocaine use data, but were included in the CSSA analysis.

REM and TST

Absolute numbers for REM and TST from the

Discussion

Although a growing body of literature has demonstrated the emergence of sleep disturbances during withdrawal from cocaine (Kowatch et al., 1992, Morgan et al., 2006, Morgan et al., 2008, Morgan et al., 2010, Pace-Schott et al., 2005, Schierenbeck et al., 2008) to our knowledge, no previous work has shown the potential impact of these sleep disturbances on human laboratory measures of cocaine self-administration or on treatment outcomes. Among individuals in the self-administration group (N = 12),

Role of funding source

NIDA (R01DA011744) and the State of Connecticut Department of Mental Health and Addiction Services (DMHAS), supported this work. The sponsors had no role in the study design, collection/analysis/interpretation of data, in the writing of the report, nor in the decision to submit this article for publication.

Contributors

P.T. Morgan designed the study and wrote the protocol. G.A. Angarita and S.V. Canavan contributed equally to this work and are co-first authors. G.A. Angarita, S.V. Canavan, E.Forselius, A. Bessette, and P.T. Morgan recruited and screened participants, collected the data, and participated in clinical care and follow up. G.A. Angarita, S.V. Canavan, and P.T. Morgan performed statistical analyses and wrote the manuscript.

Conflict of interest

No conflict declared.

Acknowledgements

We would also like to thank the staff of the Clinical Neuroscience Research Unit (CNRU) at the Connecticut Mental Health Center (CMHC).

References (70)

  • M. Haack et al.

    Sustained sleep restriction reduces emotional and physical well-being

    Pain

    (2005)
  • A.L. Hoff et al.

    Effects of crack cocaine on neurocognitive function

    Psychiatry Res.

    (1996)
  • M.D. Horner

    Attentional functioning in abstinent cocaine abusers

    Drug Alcohol Depend.

    (1999)
  • L. Huang et al.

    Polysomnographically determined sleep and body mass index in patients with insomnia

    Psychiatry Res.

    (2013)
  • K.M. Kampman et al.

    Reliability and validity of the cocaine selective severity assessment

    Addict. Behav.

    (1998)
  • K.M. Kampman et al.

    A double-blind, placebo-controlled trial of topiramate for the treatment of comorbid cocaine and alcohol dependence

    Drug Alcohol Depend.

    (2013)
  • D. Matuskey et al.

    A multistudy analysis of the effects of early cocaine abstinence on sleep

    Drug Alcohol Depend.

    (2011)
  • D. Matuskey et al.

    Dopamine D3 receptor alterations in cocaine-dependent humans imaged with [11C](+) PHNO

    Drug Alcohol Depend.

    (2014)
  • P.T. Morgan et al.

    Sleep, sleep-dependent procedural learning and vigilance in chronic cocaine users: evidence for occult insomnia

    Drug Alcohol Depend.

    (2006)
  • T.F. Newton et al.

    Irritability following abstinence from cocaine predicts euphoric effects of cocaine administration

    Addict. Behav.

    (2003)
  • D. Nutt et al.

    Development of a rational scale to assess the harm of drugs of potential misuse

    Lancet

    (2007)
  • N.M. Petry

    A comprehensive guide to the application of contingency management procedures in clinical settings

    Drug Alcohol Depend.

    (2000)
  • T. Schierenbeck et al.

    Effect of Illicit recreational drugs upon sleep: cocaine, ecstasy and marijuana

    Sleep Med. Rev.

    (2008)
  • N. Stulz et al.

    Psychosocial treatments for cocaine dependence: the role of depressive symptoms

    Drug Alcohol Depend.

    (2011)
  • P.M. Thompson et al.

    Polygraphic sleep measures differentiate alcoholics and stimulant abusers during short-term abstinence

    Biol. Psychiatry

    (1995)
  • S.S. Yoo et al.

    The human emotional brain without sleep—a prefrontal amygdala disconnect

    Curr. Biol.

    (2007)
  • R.P. Allen et al.

    Recovery time for alcoholics after prolonged alcohol intoxication

    Johns Hopkins Med. J.

    (1971)
  • R.P. Allen et al.

    Do sleep patterns relate to the desire for alcohol?

    Adv. Exp. Med. Biol.

    (1975)
  • R.P. Allen et al.

    Slow wave sleep changes: alcohol tolerance and treatment implications

    Adv. Exp. Med. Biol.

    (1977)
  • E.S. Barratt et al.

    The effects of marijuana on human sleep patterns

    Biol. Psychiatry

    (1974)
  • R.M. Benca et al.

    Sleep and psychiatric disorders. A meta-analysis

    Arch. Gen. Psychiatry

    (1992)
  • K.I. Bolla et al.

    Sleep disturbance in heavy marijuana users

    Sleep

    (2008)
  • K.J. Brower et al.

    Polysomnographic and subjective sleep predictors of alcoholic relapse

    Alcohol Clin Exp Res.

    (1998)
  • K.J. Brower et al.

    Effects of age and alcoholism on sleep: a controlled study

    J. Stud. Alcohol

    (2001)
  • K.J. Brower et al.

    Insomnia, self-medication, and relapse to alcoholism

    Am. J. Psychiatry

    (2001)
  • Cited by (23)

    • Insomnia due to drug or substance abuse and dependence

      2023, Encyclopedia of Sleep and Circadian Rhythms: Volume 1-6, Second Edition
    • Reregulation of cortisol levels and sleep in patients with prescription opioid use disorder during long-term residential treatment

      2021, Drug and Alcohol Dependence
      Citation Excerpt :

      Activation of the HPA axis at bedtime can lead to arousal and sleeplessness, whereas sleep, particularly deep sleep, has an inhibiting influence on the HPA axis (Chrousos et al., 2016; Vgontzas et al., 1999). A growing literature supports the assertion that the chronic use of substances of abuse leads to chronic alterations in sleep that are independent of the acute effects of the drug (Angarita et al., 2014). Importantly, these alterations often persist well into a drug-free period.

    • Interaction between cocaine use and sleep behavior: A comprehensive review of cocaine's disrupting influence on sleep behavior and sleep disruptions influence on reward seeking

      2021, Pharmacology Biochemistry and Behavior
      Citation Excerpt :

      Further, cocaine-induced plasticity of the DA, orexin, and adenosine systems may be the means by which sleep disturbance continues into withdrawal and abstinence conditions, long after any disturbance can be attributed to direct cocaine effects. The protracted sleep disturbance has implications for maintenance of abstinence based on correlational evidence of long-lasting risk for relapse (measured up to 6 weeks; Angarita et al., 2014a). We now have direct evidence that this sleep disturbance increases the rewarding properties of cocaine (Bjorness and Greene, 2020).

    View all citing articles on Scopus

    Supplementary material can be found by accessing the online version of this paper at http://dx.doi.org and by entering doi:….

    1

    Indicates shared first authorship.

    2

    University of Chicago, 5841 S. Maryland Avenue, O-132, MC 2121, Chicago, IL 60637, United States.

    View full text